5 years ago

Cardiovascular highlights from non-cardiology journals

Levosimendan for hemodynamic support after cardiac surgery

Left ventricular dysfunction following cardiac surgery remains a significant perioperative challenge, one often treated with inotropic support, however practice patterns vary widely and there are few outcome data to support a standardised practice. Levosimendan represents a newer class of ‘inodilators’, calcium sensitizers, thought to improve cardiac output without increasing myocardial oxygen consumption. In the Levosimendan to Reduce Mortality in High Risk Cardiac Surgery Patients (CHEETAH) randomised trial, 506 patients with a preoperative ejection fraction <25%, a preoperative need for intraaortic balloon pump (IABP) support, or post-operative need for support with IABP or high-dose inotropes within 24 hours of cardiopulmonary bypass were randomised 1:1 to receive either levosimendan infusion or placebo plus standard medical therapy in a double-blinded fashion. The primary outcome of the study was 30 day mortality. No difference in the primary outcome was found between the levosimendan group (12.9% mortality) and the...

Publisher URL: http://heart.bmj.com/cgi/content/short/103/19/1553

DOI: 10.1136/heartjnl-2017-312223

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.